ENDRA Life Sciences Inc. (NDRA)
Builds ultrasound technology that creates clearer images of liver disease and tissue composition.
$4.57-0.05%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-5.6%
The outlook
NDRA trades near its 52-week lows, well below both its 50- and 200-day moving averages, reflecting a downward trend. Analyst coverage suggests a notably bullish average price target roughly 4.5x the current price, though this sits against the stock's recent weakness and the current bearish sentiment score of 31/100.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range23% of the way from its 52-week low to high
Price targetAvg target +447% vs current price
Market cap
$5.8M
52-wk high
$9.85
52-wk low
$2.96
50-day avg
$5.09
200-day avg
$4.93
Trailing P/E
—